Dr. Shahin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
599 West State Street
Alliance Cancer Specialists
Doylestown, PA 18901Phone+1 215-345-8444Fax+1 215-345-8298
Summary
- Dr. Mark Shahin is a Gynecologic Oncologist at Alliance Cancer Specialists and is a professor of Obstetrics and Gynecology at Sidney Kimmel College of Medicine at Thomas Jefferson University. He has affiliations with multiple hospitals in the area, including Doylestown Hospital, St Mary's Medical Center, Jefferson Torresdale Hospital, Jefferson Abington Hospital, Thomas Jefferson University Hospitals, and Einstein Medical Center Montgomery. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 24 years. He specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, gynecologic oncology, clinical research, and minimally invasive gynecologic surgery.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1997 - 1998
- McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1993 - 1997
- Northwestern University The Feinberg School of MedicineClass of 1993
Certifications & Licensure
- PA State Medical License 2001 - 2024
- IA State Medical License 1997 - 2003
- IL State Medical License 1993 - 1999
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2011-2016
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Seprafilm® for Prevention of Adhesions at Repeat Cesarean Start of enrollment: 2008 Jul 01
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer Start of enrollment: 2020 Sep 01
Roles: Principal Investigator, Contact
- A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery Start of enrollment: 2016 Aug 01
Roles: Contact
Publications & Presentations
PubMed
- Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomiz...Matthew A Powell, David Cibula, David M O'Malley, Ingrid Boere, Mark S Shahin
Gynecologic Oncology. 2024-11-11 - Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André, Angela Jain
British Journal of Clinical Pharmacology. 2024-11-08 - Vaginal lacerations during laparoscopic hysterectomy for endometrial cancer and local recurrence risk.Olivia Nicolais, Mackenzie Cummings, Tommy R Buchanan Jr, Lea Moukarzel, Nicholas Cardillo
Gynecologic Oncology Reports. 2024-08-01
Press Mentions
- 'I Think About the Lives Saved': What We Heard This WeekMarch 22nd, 2019
Professional Memberships
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: